Dog Canine Cognitive Dysfunction Welfare

Canine cognitive dysfunction syndrome (CDS) is an under-recognised dementia-like condition in older dogs that causes significant behavioural changes and welfare compromise.

Key Facts

CDS affects an estimated 28% of dogs aged 11-12 and over 68% of dogs aged 15-16.
Signs include disorientation, confusion, night-time vocalisation, house soiling, reduced social interaction, and sleep cycle reversal.
CDS is associated with amyloid plaque accumulation in the brain — pathologically similar to Alzheimer's disease in humans.
Selegiline (Anipryl) is an approved medication for CDS that can slow progression and reduce symptom severity in some dogs.
Dietary antioxidants, omega-3 supplementation, and continued moderate mental enrichment may slow cognitive decline.

Welfare Considerations

CDS causes genuine confusion and distress in affected dogs. A dog that stands at the wrong side of a door, fails to recognise family members, or vocalises anxiously through the night is experiencing something genuinely disorienting. The welfare impact on the dog is significant, but the condition is also extremely difficult for owners — caring for a dog with dementia-like symptoms requires patience, environmental modification, and sometimes difficult decisions about quality of life. Early recognition and intervention provides the best welfare outcomes.

What You Can Do

Schedule twice-yearly veterinary checks for dogs over 10 — early CDS detection allows earlier intervention.
Maintain consistent daily routines for dogs with CDS — predictability reduces confusion and anxiety.
Ask your vet about selegiline and dietary approaches that may slow cognitive decline.
Use nightlights, consistent furniture placement, and scent markers to help disoriented dogs navigate.